Sage Therapeutics, Inc. reports

Company location: Cambridge, MA
Fiscal year end: 31 December

Sage Therapeutics, Inc. has filed 818 SEC EDGAR filings since 21 Jan 2014

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 426-450 of 818 matching filings.

Per page

25

Current page

18

8-K File 001-36544

8-K

Filing date: 12 Nov 2019
Reporting date: 12 Nov 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 12 Sep 2019
Reporting date: 11 Sep 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 05 Sep 2019
Reporting date: 04 Sep 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 16 Aug 2019
Reporting date: 15 Aug 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36544

10-Q

Filing date: 06 Aug 2019
Reporting date: 30 Jun 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36544

8-K

Filing date: 06 Aug 2019
Reporting date: 06 Aug 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 29 Jul 2019
Reporting date: 25 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 29 Jul 2019
Reporting date: 25 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 29 Jul 2019
Reporting date: 25 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 29 Jul 2019
Reporting date: 25 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 29 Jul 2019
Reporting date: 25 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 29 Jul 2019
Reporting date: 25 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jul 2019
Reporting date: 25 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36544

8-K

Filing date: 24 Jul 2019
Reporting date: 24 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Jul 2019
Reporting date: 17 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Jul 2019
Reporting date: 16 Jul 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jun 2019
Reporting date: 21 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jun 2019
Reporting date: 21 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jun 2019
Reporting date: 21 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jun 2019
Reporting date: 21 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 25 Jun 2019
Reporting date: 21 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36544

8-K

Filing date: 14 Jun 2019
Reporting date: 14 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36544

8-K

Filing date: 06 Jun 2019
Reporting date: 05 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jun 2019
Reporting date: 05 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Jun 2019
Reporting date: 05 Jun 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .